- Home
- ASND
ASND
Ascendis Pharma A/S
as 03-28-2025 4:00pm EST
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.
| Founded: | 2006 | Country: | Denmark |
| Employees: | N/A | City: | N/A |
| Market Cap: | 9.9B | IPO Year: | 2015 |
| Target Price: | $201.79 | AVG Volume (30 days): | 432.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 14 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -6.76 | EPS Growth: | N/A |
| 52 Week Low/High: | $111.09 - $169.37 | Next Earning Date: | 05-01-2025 |
| Revenue: | $376,478,932 | Revenue Growth: | 36.34% |
| Revenue Growth (this year): | 58.89% | Revenue Growth (next year): | 75.85% |
Latest Ascendis Pharma A/S News
ASND Breaking Stock News: Dive into ASND Ticker-Specific Updates for Smart Investing
Zacks
13 days ago
Ascendis Pharma (ASND) Soars 10.4%: Is Further Upside Left in the Stock?
Simply Wall St.
a month ago
Exploring US High Growth Tech Stocks In March 2025
GlobeNewswire
a month ago
Ascendis Pharma to Participate in the TD Cowen 45th Annual Health Care Conference
Simply Wall St.
a month ago
Ascendis Pharma A/S (NASDAQ:ASND) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
Simply Wall St.
a month ago
Ascendis Pharma Full Year 2024 Earnings: Beats Expectations
GuruFocus.com
a month ago
Ascendis Pharma AS (ASND) Q4 2024 Earnings Call Highlights: Strategic Growth and Market ...
Benzinga
2 months ago
Why Is Rare Disease Focused Ascendis Pharma Stock Trading Higher On Thursday?
MT Newswires
2 months ago
Ascendis Pharma Allocates $25 Million for Share Repurchases, Net Settlement of RSUs
Compare ASND vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ASND Ascendis Pharma A/S - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.